SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-16-085842
Filing Date
2016-11-10
Accepted
2016-11-10 16:32:40
Documents
42
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 ONCOCYTE CORPORATION 10-Q 9-30-2016 form10q.htm 10-Q 406320
2 EXHIBIT 31 ex31.htm EX-31 13081
3 EXHIBIT 32 ex32.htm EX-32 4691
  Complete submission text file 0001140361-16-085842.txt   2498328

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ocx-20160930.xml EX-101.INS 364641
5 XBRL TAXONOMY EXTENSION SCHEMA ocx-20160930.xsd EX-101.SCH 24803
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ocx-20160930_cal.xml EX-101.CAL 39072
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ocx-20160930_def.xml EX-101.DEF 93554
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocx-20160930_lab.xml EX-101.LAB 362083
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocx-20160930_pre.xml EX-101.PRE 202620
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 161988513
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences